Navigation Links
Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease
Date:12/1/2011

rsity of Pennsylvania; Columbia University Medical Center; Rush University Medical Center; Beth Israel Medical Center, NY; and Mount Sinai Medical Center, NY.

About CERE-120 and its Application to Treating Parkinson's Disease
CERE-120 is composed of an adeno-associated virus (AAV) vector carrying the gene for neurturin, a naturally occurring protein known to repair damaged and dying dopamine-secreting neurons, keeping them alive and restoring normal function.  Neurturin is a member of the same protein family as glial cell-derived neurotrophic factor (GDNF).  The two molecules have similar pharmacological properties, and both have been shown to benefit the midbrain dopamine neurons that degenerate in Parkinson's disease.  Degeneration of these neurons is responsible for the major motor impairments of Parkinson's disease.  CERE-120 is delivered by stereotactic injection to the terminal fields (i.e., the ends of the degenerating neurons), located in an area of the brain called the putamen, as well as the cell bodies for these same neurons, located in a different area of the brain, called the substantia nigra.  Once CERE-120 is delivered to the brain, it provides stable, long-lasting expression of neurturin in a controlled and highly targeted fashion.

About Parkinson's Disease
Parkinson's disease is a progressive movement disorder that affects a million people in the United States.  Its main symptoms, stiffness, tremors and slowed movements and gait, are caused by a loss of dopamine-containing nerve cells in the substantia nigra, which project their axons to the putamen.  Dopamine is a neurotransmitter involved in controlling movement and coordination, so Parkinson's patients exhibit a progressive inability to initiate and control physical movements.  There is currently no treatment that can reverse the degeneration of these neurons, let alone cure Parkinson's disease.


'/>"/>

SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinsons Disease
2. Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinsons Disease
3. Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinsons Disease
4. ETCs Aircrew Training Systems Completes Factory Acceptance Tests for Highly Advanced Suite of Training Equipment for the Republic of Korea Air Force Aeromedical Center
5. Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital
6. Par Pharmaceutical Completes Acquisition of Anchen
7. Mylan Successfully Upsizes and Completes Refinancing of Credit Facility
8. New Spot Vision Screener Completes School Screening in Less Than Two Hours
9. MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation
10. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
11. Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... OAKS, Calif. , May 16, 2013  Amgen (NASDAQ: ... Life Sciences Conference on Tuesday, May 21, 2013, at the ... City , beginning at 10:00 a.m. Eastern Daylight Time. ... vice president of Research and Development at Amgen, will present ... accessed from the Events Calendar on Amgen,s website, www.amgen.com ...
(Date:5/16/2013)... , May 16, 2013 ... in the U.S. to access the widely-used OrthoView digital ... PC and Internet connection to get started. ... software for over 10 years, is dedicated to enabling ... with digital x-ray images, when printed film is unavailable. ...
(Date:5/16/2013)... , May 16, 2013 Developers of a pill ... reminders have emerged as grand prize winners in the ... funded by Boehringer Ingelheim and organized by HITLAB . ... , John Langhauser and ... the United States will receive $50,000 ...
Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5
... Johnson & Johnson Pharmaceutical,Research & Development, L.L.C. ... showed that investigational antibiotic ceftobiprole was found to,clinically ... -- including,some infections that were caused by methicillin-resistant ... the 45th annual meeting of the Infectious,Disease Society ...
... 3 clinical development program will examine HZT-501 as ... NSAID for mild to moderate pain -, ... Inc., a,privately held biopharmaceutical company, today announced that ... (protocol HZ-CA-304) of its lead,product candidate HZT-501, an ...
Cached Medicine Technology:New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 2New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 3New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 4Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501 2Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501 3
(Date:5/19/2013)... May 19, 2013 According to ... Analysis and Forecast (2013 – 2018): By Applications ... Industrial)); Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) ... image sensor market was $8.00 billion in 2012 ... 2018, at an estimated CAGR of 3.84% from ...
(Date:5/19/2013)... New York, New York (PRWEB) May 19, 2013 ... note that a Case Management Conference was recently convened ... in a federal multidistrict litigation now underway in U.S. ... Minutes posted on the Court’s website on May 14th, ... motions. It was also reported during the Conference ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...
(Date:5/19/2013)... Beginning Wednesday, May 29 and running through Wednesday, August ... “Hot Dog Wednesdays" and Ice Cold Slushies at donor centers ... and all the fixin's to donors on Wednesdays. RRVBC ... “Donors are our lifeline. The summer months are an especially ... This is a small way for us to thank ...
(Date:5/19/2013)... The legal team at Pulaski & ... concerted effort to connect women and families coping with ... Yaz, Yasmin & Ocella with the legal representation they ... the notorious birth control drugs as well as news ... Yaz, Yasmin & Ocella were very popular birth control ...
Breaking Medicine News(10 mins):Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2
... Live Event ... Optimize Available Resources , ... VA (PRWEB) May 11, 2010 -- Harmony Information Systems Inc ., the leader in ... Vermont and Pennsylvania Are Taking Control of Medicaid Waivers Management ,” scheduled for Wednesday, May ...
... ... an Interpretive Dance Video. , ... Seattle, WA (PRWEB) May 11, 2010 -- Onlineshoes.com is proud to announce ... campaign featuring an interpretive dance video. , , ,Pronounced “cushy”, Cushe is a ...
... ... been recognized as a silver SugarCRM implementation partner providing best-practice implementation services ... the last two years as a leading player in producing advanced sales and marketing ... ...
... Melanoma and ... is linked to cancer risk. Practical and clinical information about skin health, melanoma and skin ... , ... -- With skin cancer on the rise for Americans under 30 and indoor tanning contributing ...
... ... million in a medical malpractice case against an obstetrician who delayed a C-section while the baby ... Division, Essex County, Docket No.: ESX-L-1906-08. , ... (PRWEB) May 11, 2010 -- On April 29, 2010 an Essex County, New Jersey jury ...
... ... noise , ... 11, 2010 -- Noisy construction by the MTA is keeping some residents in Brooklyn up ... have had no effect. Construction accident attorneys in New York are familiar with the ...
Cached Medicine News:Health News:Harmony Information Systems to Host Free Webcast: Learn How Vermont and Pennsylvania Are Taking Control of Medicaid Waivers Management 2Health News:Harmony Information Systems to Host Free Webcast: Learn How Vermont and Pennsylvania Are Taking Control of Medicaid Waivers Management 3Health News:Onlineshoes.com and Cushe Team Up to Offer Men and Women Shoes for Casual Living 2Health News:Onlineshoes.com and Cushe Team Up to Offer Men and Women Shoes for Casual Living 3Health News:ApexTwo and SugarCRM Announce New Implementation Partnership 2Health News:Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians 2Health News:Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians 3Health News:$18.5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C-Section 2Health News:New York Construction Accident Attorney, David Perecman, Supports MTA Night Work 2
Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
A simple, in-office test for the detection of mononucleosis. Easy to use with fast, accurate results within minutes....
... Burgdorferi Antibody Detection Assay is a single ... presumptive (first step) detection of IgG and ... serum or whole blood. Rapid turnaround time, ... the Wampole PreVue B. burgdorferi antibody detection ...
Medicine Products: